BIIR 561 CL

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

Single Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Elderly Male and Female Volunteers

CompletedNCT02223507

Boehringer IngelheimHealthy

Start: 2000-08-31Target: 13Updated: 2014-08-22

Single Increasing Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Male Volunteers

CompletedNCT02222961

Boehringer IngelheimHealthy

Start: 1999-11-30Target: 60Updated: 2014-08-22

Single Increasing Dose Tolerance Study in Healthy Male Volunteers of BIIR 561 CL

CompletedNCT02222974

Boehringer IngelheimHealthy

Start: 1999-01-31Updated: 2014-08-22